A Novel RP-HPLC-DAD Method Development for Anti-Malarial and COVID-19 Hydroxy Chloroquine Sulfate Tablets and Profiling of In-Vitro Dissolution in Multimedia.
Anti malaria
COVID-19
Dissolution
Hydroxy chloroquine sulfate
validation
Journal
Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035
Informations de publication
Date de publication:
05 May 2020
05 May 2020
Historique:
pubmed:
24
7
2020
medline:
24
7
2020
entrez:
24
7
2020
Statut:
epublish
Résumé
Hydroxychloroquine sulfate is one of a large series of 4-aminoquinolines with antimalarial activity. Moreover, it is used for the treatment of rheumatoid arthritis. Sometimes Hydroxychloroquine sulfate is very effective for the treatment of autoimmune diseases. Based on the recent clinical experiments it is exploiting for the treatment of COVID-19, corona virus across the globe. A Reverse phase RP-HPLC method have been developed and validated as per the current ICH guidelines for estimation of Hydroxychloroquine sulfate tablets. As part of method validation specificity, linearity, precision and recovery parameters were verified. The concentration and area relationships were linear (R
Identifiants
pubmed: 32702733
doi: 10.21203/rs.3.pex-880/v2
pmc: PMC7336707
pii:
doi:
Types de publication
Preprint
Langues
eng